NCT02460952

Brief Summary

The purpose of this study is to investigate the prevention of Pulmonary Embolism in Patients who With General Anesthesia Operation in Perioperative Period.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2014

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

June 3, 2015

Status Verified

June 1, 2015

Enrollment Period

1.4 years

First QC Date

June 1, 2015

Last Update Submit

June 2, 2015

Conditions

Keywords

Pulmonary Embolism;perioperative period;general anesthesia

Outcome Measures

Primary Outcomes (1)

  • The changes of patients'Lower extremity vein in perioperative period of general anesthesia operation

    3 days before operation to 7 days after the operation

Eligibility Criteria

Age45 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients accept Operation with general anesthesia

You may qualify if:

  • The first time to accept the general anesthesia operation

You may not qualify if:

  • Pregnancy.
  • The function of liver and kidney disorder or serious abnormal electrolyte.
  • The abnormal coagulation dysfunction and blood volume.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liu Sijie

Beijing, Beijing Municipality, 100020, China

RECRUITING

MeSH Terms

Conditions

Pulmonary Embolism

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • yingmin ma, doctor

    Vice president of Beijing Chaoyang Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice president of Beijing Chaoyang Hospital

Study Record Dates

First Submitted

June 1, 2015

First Posted

June 3, 2015

Study Start

August 1, 2014

Primary Completion

January 1, 2016

Study Completion

August 1, 2016

Last Updated

June 3, 2015

Record last verified: 2015-06

Locations